The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices ... in anticompetitive practices that spur price ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming unfair practices inflated the cost of insulin.

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

In addition, insulin has become more expensive, with the cost of some formulations increasing by almost 600 percent in recent ...

It can be used by consumers aged 18 years and older who are not on insulin. The system is worn ... A key factor driving market growth is the increase in the prevalence of diabetes due to aging ...

It can also increase the risk of developing type 2 diabetes later in life for both you and your child. If your pancreas produces little or no insulin — or if your body can’t use it — other ...